pr-2007 - Lupin

HOME

LUPIN FOUNDATION

CAREERS Careers Overview Life at Lupin Campus Connect Learning & Development Current Openings P.L.E.D.G.E.

CONTACT US Contact Us Global Offices Partner With Us Lupin for Suppliers GST Information

Menu

FEATURED

Lupin gets new Pharmaceutical Research Head

November 13, 2007

Lupin FY 2007-08 Q2 Consolidated Net Profit up 46% to Rs. 756 mn

October 24, 2007

Lupin acquires in Japan

October 10, 2007

Lupin acquires pharmaceutical business of Rubamin

September 27, 2007

Lupin wins Ramipril product patent challenge at Federal Circuit

Septeber 12, 2007

Lupin appoints Ramesh Swaminathan as President Finance & Planning

August 13, 2007

Lupin Receives "Best New Manufacturer of the Year" Award fromAmerisourceBergen

July 31, 2007

Lupin FY 2007-08 Q1 Net Profit up 55% to Rs. 784 mn

July 19, 2007

Lupin receives DCGI Approval to conduct Combined Phase IIb/III Clinical Trials for it's herbal Psoriasis NCE

July 18, 2007

Lupin Receives US FDA Approval for Amlodipine

July 17, 2007

Lupin gets MHRA Approval for Lisinopril in UK

July 2, 2007

Lupin receives Final FDA Approval for Trandolapril

June 14, 2007

Lupin Receives US FDA Approval for Cefadroxil Capsules

May 31, 2007

Lupin and Symbiotec decide not to pursue their MoU

May 31, 2007

Lupin receives tentative US FDA Approval for Ziprasidone

May 21, 2007

Lupin Receives US FDA Approval for Simvastatin Tablets

May 15, 2007

DST and Lupin join hands over Migraine and Psoriasis

April 27, 2007

Lupin receives US FDA Approval for Novel Formulation of Suprax® Suspension

April 12, 2007

Lupin gets Marketing Approval for Cefpodoxime Proxetil in France

March 13, 2007

Lupin sells Intellectual Property on Perindopril to Servier

February 20, 2007

Lupin receives US FDA approval for Sertraline

February 7, 2007

Lupin and Aspen decide not to pursue their MOU

January 19, 2007

Lupin FY 2006-07 Q3 Net Profit up by 27% at Rs.560 mn

January 17, 2007

Lupin gets tentative US FDA approval for Sertraline

January 2, 2007